www.fdanews.com/articles/97004-paladin-expands-distribution-agreement-with-shire-hgt-to-include-elaprase-idursulfase
Paladin Expands Distribution Agreement With Shire HGT to Include Elaprase (Idursulfase)
August 9, 2007
Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, announced that it has expanded its current exclusive Canadian distribution agreement with Shire Human Genetic Therapies, Inc.
Marketwire